Insights on scaling B2B revenue

Deals don't always die cleanly - they linger. When close dates keep slipping and champions go quiet, most pipelines are carrying losses that haven't been called yet. That distorts forecasts, wastes selling time, and masks the real coverage problem.

Proven product, real hospital deployments, strong supplier interest - and a CEO carrying every major commercial conversation alone. This is how MediShout moved from early traction to seven-figure ARR by fixing the commercial execution layer, not the product.

Most sales incentive plans fail not because the numbers are wrong, but because they're trying to do too much. One primary metric, tight management discipline, and genuine simplicity will outperform any cleverly engineered structure.

In a complex sale, most of the conversations happen without you in the room. What determines the outcome is whether each stakeholder can recall and repeat a simple, specific reason why you're the right choice - and whether you've shaped what that reason is.

Most sellers can identify a prospect's problem. Far fewer can make the prospect feel it urgently enough to act. The difference between a deal that stalls and one that moves comes down to whether pain is genuinely implicated across the business.

When price pressure appears, most sales teams default to discounting before they fully understand what the buyer actually needs. This case study shows how agilio restructured negotiation behaviour across a 14-person team - and what changed commercially when they did.